UPDATE: Abbvie (ABBV) PT Lowered to $116 at Morgan Stanley on Lower Rinvoq Sales
Tweet Send to a Friend
(Updated - January 28, 2021 7:57 AM EST)
Morgan Stanley analyst David Risinger lowered the price target on Abbvie ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Morgan Stanley analyst David Risinger lowered the price target on Abbvie ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
